Skip to main content
Loading

Garuda Therapeutics, Inc.

October 18, 2023
Franciscan B
Gene/Cell Therapy
Garuda Therapeutics seeks to create a world that eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible and transgene-free blood stem cell therapies. Like bone marrow transplants, our technology could provide potentially curative therapies for more than 120 diseases
Speakers
Dhvanit Shah, President and CEO - Garuda Therapeutics, Inc.

Company Type

Privately Funded

Website

https://garudatx.com/

CEO/Top Company Official

YES

Lead Product in Development

Off-the-shelf hematopoietic stem cells

Number Of Unlicensed Products

2

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS